Evaluation of Mer and Axl Expression in Acute Myeloid Leukemia Patient Samples
OBJECTIVES:
- To evaluate Mer and Axl expression in samples from pediatric patients with acute
myeloid leukemia (AML).
- To determine if abnormal expression of Mer and Axl is associated with poor clinical
characteristics (e.g., induction failure or relapse) of AML in these patients.
OUTLINE: This is a multicenter study.
Archived samples from pediatric patients with acute myeloid leukemia are analyzed for Mer
and Axl expression by flow cytometry and western blot assays.
Observational
N/A
Expression of Mer and Axl
No
Kristen M. Eisenman, MD
Principal Investigator
University of Colorado, Denver
United States: Federal Government
CDR0000671452
NCT01139333
September 2009
Name | Location |
---|